Objective: We aimed to investigate the relationship between day-1 hypoproteinemia and severe adverse outcome (SAO) in very preterm infants admitted to the neonatal intensive care unit (NICU).
Introduction
Total protein concentration is the major determinant of colloid oncotic pressure (COP) and it has been regarded as predictor of morbidity and mortality in acute illness. In critically ill adults admitted to the intensive care unit, hypoproteinemia is actually recognized as a prognostic factor of poor outcome. 1 Similar results are reported for hypoalbuminemia. 2 Even if it is recognized that albumin is the most abundant protein in blood plasma, constituting up to two-thirds of total protein in adults as in newborn babies, 3, 4 there is some evidence that in critically ill patients total protein concentration may reflect COP better than serum albumin concentration, 4 thus representing one more interesting predictor for poor outcome.
In newborn babies, the relationship between low serum protein and unfavorable outcome has never been explored, while hypoalbuminemia has been related to increased morbidity and mortality in some specific illness, such as gastrointestinal diseases. 5, 6 One retrospective report over a small sample size of very low birth weight (BW) infants has shown a significant association between low albumin levels and mortality. In this study, the recorded albumin measurements were not realized at standardized times, with some being performed more than a week after birth. 7 These observations have led us to perform a study to determine the relationship between hypoproteinemia on the first day of life and severe adverse outcome (SAO) in a large cohort of critically ill infants born below 32 weeks gestation.
Patients and methods
Design and study population The study design was an observational retrospective cohort analysis of all the infants born from 24 to 31 weeks of gestational age (GA) and admitted to the neonatal intensive care unit (NICU) of Dijon University Hospital during an 8-year period (1 January 2001 to 31 December 2008). According to previous published guidelines for assessing fluid and electrolyte status in very low BW infants, 8 all babies born <32 weeks of GA and hospitalized in our NICU had a blood sample at 12 h of life. This blood sample systematically provided the serum total protein measurement.
All the infants admitted to the NICU within 6 h after birth were eligible.
According to the NICU nutritional practices, all these infants had a total parenteral nutrition started into the first hours of life.
Patients were excluded if the serum protein value on the first day of life was not available or if they had major congenital malformations.
Outcome measures SAO was defined as death and/or severe (grade 3 or 4) intraventricular hemorrhage (IVH) and/or cystic periventricular leukomalacia (c-PVL) occurring before infant's discharge from hospital. IVH was graded at cerebral ultrasound according to Papile et al. 9 c-PVL was defined by cranial ultrasound as an area of increased echogenicity of the periventricular white matter in acute phase, which subsequently evolved into cystic lesion. 10 Cranial ultrasounds were routinely performed during the infant hospital stay by experienced examiners (neonatologists or radiologists) according to the following protocol: day 1, 3, 7, 10, 15 and then at least every 2 weeks or more often as clinically indicated, until discharge.
Data collection
Clinical data. Clinical data on the population were obtained from the regional perinatal database of the Burgundy Perinatal Network. 11, 12 This perinatal database was set up with the approval of the National Committee of Informatics and Liberty, and prospectively records clinical events for mothers and infants between birth and hospital discharge. Information was collected about antenatal history: maternal age, hypertensive disease of pregnancy, placental diseases (placental abruption, placenta praevia), preterm prelabor rupture of membranes, threatened preterm labor, diabetes, antenatal steroids administration, singleton or multiple pregnancy, clinical chorioamnionitis and mode of delivery. The following data about birth and postnatal diseases were also collected: GA, BW, gender, appropriateness of BW for GA (according to reference Hadlock FP et al. 13 ), transfer after birth (outborn), 1 min Apgar score, anemia at birth (venous hemoglobin <13.3 g dl À1 at the admission in NICU), 14 early onset sepsis (EOS), respiratory distress syndrome (RDS) requiring surfactant, acute renal failure, 15 hemodynamically significant patent ductus arteriosus, late onset sepsis, necrotizing enterocolitis and bronchopulmonary dysplasia. The GA in completed weeks was assessed on the basis of the mother's last menstrual period, and confirmed or modified when necessary by routine early antenatal ultrasound examination. GA was divided into three categories with cutoff points at 25, 27 and 31 weeks gestation.
Total protein values
Laboratory values for serum total protein were available from the infants' medical records.
Hypoproteinemia was defined as a total protein level of <40 g l À1 on the first day of life. 16 
Statistical analysis
The hypoproteinemic patients were compared with the normoproteinemic ones with respect to SAO. Univariate analysis using one-factor analysis of variance was performed to investigate perinatal variables associated with hypoproteinemia. Variables significant at a P-level <0.20 at the univariate analysis were entered into a backward selection analysis of variance.
Univariate analysis was performed to estimate the association of SAO with all the other available perinatal variables and with postnatal diseases occurring on the first day of life (RDS requiring surfactant, EOS and birth anemia).
To estimate the independent influence of hypoproteinemia on SAO, we realized a logistic multiple regression model. The model used eight predictor variablesFhypoproteinemia and seven potentially confounding baseline variables. These were selected because they represented either factors identified as associated with SAO at a P-level <0.20 in the univariate analysis or as variables independently associated with hypoproteinemia, or both.
We used Pearson w 2 or Fischer exact test for qualitative variables, and one-way analysis of variance or Mann-Whitney test for comparing quantitative variables distributions between infants groups. The multivariate regression model was realized using a backward elimination approach. The adjusted odds ratio and their confidence intervals were estimated.
Statistical analyses were performed using SAS software 8.2 (SAS Institute, Cary, NY, USA). All hypotheses were tested at the 2-tailed 0.05 significance level.
Results

Study population
Among the 1067 infants admitted to the NICU during the study period, none had major congenital malformations, and total protein value on the first day of life was not available for 154 infants (14%). So, the study population included 913 infants.
Outcome and clinical data SAO was present in 14.6% of the study population, with 8.2% of death and 6.4% of survival with severe cerebral ultrasound findings (IVH grade 3-4 and/or c-PVL). Death occurred during the first week of life in 3.2% of patients and later during the hospital stay in 4.9%. Table 1 shows perinatal characteristics of the study population, characteristics at birth and postnatal diseases.
Patients included in the analysis were not different with regard to GA, BW and frequency of SAO when compared with those excluded owing to missing data for serum protein values (data not shown). Figure 1 ).
Variables associated with hypoproteinemia at the univariate analysis were: multiple pregnancy, hypertensive disease of pregnancy, threatened preterm labor, lack of antenatal steroids, low GA, small for GA BW, male gender, Apgar score <3 at 1 min of life, cesarean section, outborn, EOS and RDS requiring surfactant (data not shown).
Variables that remained associated with hypoproteinemia at the multivariate analysis are detailed in Table 2 .
Clinical factors significantly associated with SAO at the univariate analysis were: lack of antenatal steroids, birth without At the multivariate analysis, hypoproteinemia on day 1 of life remained a strong independent factor positively associated with SAO. Higher GA, cesarean section and Apgar score >3 at 1 min of life showed a significant protective effect (results are shown in Table 3 ).
Discussion
This is to our knowledge the first paper showing an independent significant association between low protein levels on the first day of life and adverse outcome in very preterm infants.
Of course, the existence of this correlation does not establish causality, but demonstrating such an association is the first step in determining whether or not a causal relationship exists.
There is evidence that low serum protein levels accompany acute RDS in critically ill adults: in this population, the higher mortality related to hypoproteinemia is driven by increased RDS severity. 1 In our series, hypoproteinemia was associated to increased rate of RDS requiring surfactant, but this latter did not represent a risk factor for SAO, so a different mechanism by which low serum protein could affect outcome may be involved.
One of the main physiological properties of serum protein resides on the maintenance of volemia by influencing the COP, and the relationship of COP with total protein is stronger in critically ill patients than in stable ones. 4 In newborn babies, a significant linear correlation between COP and total protein in cord blood has been described by Kero et al., 17 and even in sick neonates, COP is correlated with total protein during the first days of life, as reported by Bhat et al. 18 In one previous investigation in newborn babies with RDS, we have described a significant positive correlation between COP, total protein and hypotension. 19 Based on all above, we can suppose that in our population protein levels reflected plasma volemia, and the decreased oncotic pressure could have impaired maintenance of intravascular volume and adequate blood flow to vital organs. This could also explain the association between hypoproteinemia and severe neurological injury as both subclinical hypoperfusion and neonatal hypotension are recognized risk factors for cerebral hemorrhage and ischemia in very low BW infants. 20, 21 The finding that serum protein levels were lower in infants who died early during hospital stay supports this hypothesis.
Regrettably, the lack of information about time of cord clamping and hypotension requiring treatment by volume expansion during the first hours of life does not allow any conclusion with respect of this point, and this is a limitation of our study.
Our study cannot draw conclusions about the cause underlying hypoproteinemia.
As reported by previous papers, 16 low protein levels were associated with lower GA in our population.
It is also interesting to note that the lack of antenatal corticosteroids was an independent variable associated with hypoproteinemia in our cohort, and this is consistent with the results of Bunt et al., showing that albumin synthesis in preterm infants on the first day of life tended to increase after administration of antenatal corticosteroids. 22 The same authors have found that albumin synthesis rates were significantly lower in preterm babies with intrauterine growth retardation, and this is in contrast with our results that show no difference with regard to the occurrence of hypoproteinemia in small for GA babies when compared with babies appropriate for GA.
Of course, the retrospective design of this study restricts the interpretation of our results; but in spite of the above limitations, the strong association between hypoproteinemia and severe impaired outcome depicted in this large population remains valid.
Moreover, our data raise the question whether there is an interest in increasing total protein levels in critically ill preterm infants admitted to the NICU. In our series, total protein determinations were available in the absence of serum albumin levels and this represents a further limitation of the present study. However, we know that in newborn infants born preterm, albumin accounts for >60% of the total blood body protein, 4 ,23 so that we can suppose that in our population protein levels paralleled albumin levels.
Nowadays, the use of albumin as a fluid for volume replacement for hypotension or as a treatment for low serum albumin levels in premature infants is an ongoing debate and it has been the subject of evidence-based reviews. 24, 25 Whether albumin infusion would be beneficial in some circumstances in preterm babies is still controversial [25] [26] [27] and our findings further raise this issue.
Of course, additional investigations are warranted in order to answer to this and to other questions that arise as a consequence of our results. In an attempt to better explore the associated risk factor that we have identified in the current work, we suggest several proposals for future prospective studies: (1) identify the predictive accuracy for adverse outcome of hypoproteinemia compared with other valid risk-adjusted scores of illness severity in very preterm Hypoproteinemia in preterm infants S Iacobelli et al infants; (2) consider the potential mechanism by which low total protein may affect outcome in preterm babies and (3) investigate whether albumin infusion may have potential benefits in preterm infants presenting with early hypoproteinemia.
